1405-9940
1405-9940
S1405-99402022000100099
10.24875/acm.21000005
Venezuela
Guatemala
Argentina
Brazil
Chile
Argentina
Colombia
USA
Venezuela
Chile
Chile
Colombia
Ecuador
Dominican Republic
Venezuela
Peru
Chile
México
Ecuador
Peru
Argentina
Venezuela
Peru
Peru
USA
Spain
USA
00
03
2022
00
03
2022
92
1
99
112
[
GBD 2017 Causes of Death Collaborators
2018
392
1736-88
]
[
2019
74
1138-50
]
[
2016
1-6
]
[
2014
13
26
]
[
Alterations Beyond LDL Expert Working Group
2017
26
16-24
]
[
2016
388
2532-61
]
[
2018
72
330-43
]
[
2016
18
C2-12
]
[
2018
137
2551-3
]
[
IMPROVE-IT Investigators
2015
372
2387-97
]
[
FOURIER Steering Committee and Investigators
2017
376
1713-22
]
[
ODYSSEY OUTCOMES Committees and Investigators
2018
379
2097-107
]
[
CM REDUCE-IT Investigators
2019
380
11-22
]
[
CANTOS Trial Group
2017
377
1119-31
]
[
2020
41
4092-9
]
[
2019
381
2497-505
]
[
LoDoCo2 Trial Investigators
2020
383
1838-47
]
[
2020
142
1890-900
]
[
2019
98
]
[
2019
150
8-16
]
[
2016
68
1116-39
]
[
PEGASUS-TIMI 54 Steering Committee and Investigators
2015
372
1791-800
]
[
COMPASS Investigators
2017
377
1319-30
]
[
2020
395
795-808
]
[
2018
122
762-7
]
[
Cholesterol Treatment Trialists'(CTT) Collaboration
2010
376
1670-81
]
[
2018
3
823-8
]
[
2017
38
2459-72
]
[
2018
114
35-52
]
[
2016
316
1289-97
]
[
2016
118
547-63
]
[
2018
12
292-9.e3
]
[
EBBINGHAUS Investigators
2017
377
633-43
]
[
FOURIER Investigators
2017
390
1962-71
]
[
2021
77
1439-50
]
[
2006
151
975.e1-9
]
[
2016
8
649-55
]
[
2013
273
44-7
]
[
2017
243
516-22
]
[
2010
55
2721-6
]
[
AIM-HIGH Investigators
2011
365
2255-67
]
[
ACCORD Study Group
2010
362
1575-85
]
[
2009
32
493-8
]
[
ORIGIN rial Investigators
2012
367
309-18
]
[
The ASCEND Study Collaborative Group
2018
379
1540-50
]
[
Omega-3 Treatment Trialists'Collaboration
2018
3
225-34
]
[
2020
1
120-3
]
[
2016
133
1073-80
]
[
2018
3
1090-5
]
[
2018
392
1311-20
]
[
2018
39
2589-96
]
[
2017
9
25
]
[
2019
139
1741-3
]
[
2017
24
44-51
]
[
2018
61
2108-17
]
[
The EMPA-REG OUTCOME Investigators
2015
373
2117-28
]
[
CANVAS Program Collaborative Group
2017
377
644-57
]
[
MS DECLARE-TIMI 58 Investigators
2019
380
347-57
]
[
2018
19
41-9
]
[
EMPEROR-Reduced Trial Investigators
2020
383
1413-24
]
[
DAPA-HF Committees and Investigators
2019
21
665-75
]
[
DAPA-CKD Trial Committees and Investigators
2020
383
1436-46
]
[
LEADER Steering Committee, LEADER Trial Investigators
2016
375
311-22
]
[
SUSTAIN-6 Investigators
2016
375
1834-44
]
[
REWIND Investigators
2019
394
121-30
]
[
2020
6
]
[
2019
380
752-76
]
[
2018
199
83-91
]
[
COMPASS Investigators
2018
391
219-29
]
[
ATLAS ACS 2-TIMI 51 Investigators
2012
366
9-19
]
[
2008
15
239-46
]
[
American Heart Association
]
[
2009
169
659-69
]
[
2018
72
3332-65
]
[
2019
14
3-16.e1
]